Literature DB >> 3415672

Inhibition of leucocyte elastase by heparin and its derivatives.

F Redini1, J M Tixier, M Petitou, J Choay, L Robert, W Hornebeck.   

Abstract

Leucocyte proteinases, e.g. leucocyte elastase and cathepsin G, are inhibited by heparin. The activities of pig pancreatic and Pseudomonas aeruginosa elastases are unaffected by this polysaccharide. Heparin derivatives of known Mr and degree of sulphation were isolated. The inhibition of leucocyte elastase by these oligosaccharides can be classified as tight-binding hyperbolic non-competitive. Ki values ranged from 40 nM to 100 microM and were found to be inversely correlated with the chain length of the oligosaccharides. Desulphated compounds lacked inhibitory potential towards leucocyte elastase. Over-O-sulphated di- and tetra-saccharides are more potent inhibitors than their over-N-sulphated counterparts. It is proposed that the therapeutic use of heparin and its derivatives could be extended to disease states such as emphysema and rheumatoid arthritis, where the role of leucocyte elastase has been clearly established.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3415672      PMCID: PMC1149174          DOI: 10.1042/bj2520515

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  A controlled study of the effect of intermittent heparin therapy on the course of human coronary atherosclerosis.

Authors:  H ENGELBERG; R KUHN; M STEINMAN
Journal:  Circulation       Date:  1956-04       Impact factor: 29.690

2.  The determination of enzyme inhibitor constants.

Authors:  M DIXON
Journal:  Biochem J       Date:  1953-08       Impact factor: 3.857

3.  A conductimetric method for the determination of sulphate and carboxyl groups in heparin and other mucopolysaccharides.

Authors:  B Casu; U Gennaro
Journal:  Carbohydr Res       Date:  1975-01       Impact factor: 2.104

4.  Oxygen radicals mediate endothelial cell damage by complement-stimulated granulocytes. An in vitro model of immune vascular damage.

Authors:  T Sacks; C F Moldow; P R Craddock; T K Bowers; H S Jacob
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

5.  Neutral proteinases of human spleen. Purification and criteria for homogeneity of elastase and cathepsin G.

Authors:  P M Starkey; A J Barrett
Journal:  Biochem J       Date:  1976-05-01       Impact factor: 3.857

6.  Graphical and statistical analysis of hyperbolic tight-binding inhibition.

Authors:  A Baici
Journal:  Biochem J       Date:  1987-06-15       Impact factor: 3.857

Review 7.  Chemistry of the hemostatic mechanism and its relationship to the action of heparin.

Authors:  R D Rosenberg
Journal:  Fed Proc       Date:  1977-01

8.  A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors.

Authors:  A Cornish-Bowden
Journal:  Biochem J       Date:  1974-01       Impact factor: 3.857

9.  Endothelial binding sites for heparin. Specificity and role in heparin neutralization.

Authors:  T Bârzu; J L Van Rijn; M Petitou; P Molho; G Tobelem; J P Caen
Journal:  Biochem J       Date:  1986-09-15       Impact factor: 3.857

10.  X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor.

Authors:  W Bode; A Z Wei; R Huber; E Meyer; J Travis; S Neumann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  17 in total

1.  Neutrophil extracellular traps (NETs) contribute to pathological changes of ocular graft-vs.-host disease (oGVHD) dry eye: Implications for novel biomarkers and therapeutic strategies.

Authors:  Seungwon An; Ilangovan Raju; Bayasgalan Surenkhuu; Ji-Eun Kwon; Shilpa Gulati; Muge Karaman; Anubhav Pradeep; Satyabrata Sinha; Christine Mun; Sandeep Jain
Journal:  Ocul Surf       Date:  2019-04-06       Impact factor: 5.033

2.  The heparin-binding lectin from ovine placenta: purification and identification as histone H4.

Authors:  A L Ambrosio; M M Iglesias; C Wolfenstein-Todel
Journal:  Glycoconj J       Date:  1997-11       Impact factor: 2.916

3.  Heparin and enoxaparin enhance endotoxin-induced tumor necrosis factor-alpha production in human monocytes.

Authors:  M Heinzelmann; M Miller; A Platz; L E Gordon; D O Herzig; H C Polk
Journal:  Ann Surg       Date:  1999-04       Impact factor: 12.969

Review 4.  Small proteoglycans.

Authors:  H Kresse; H Hausser; E Schönherr
Journal:  Experientia       Date:  1993-05-15

5.  Unfractionated heparin protects the protein C system against lipopolysaccharide-induced damage in vivo and in vitro.

Authors:  Dongmei Zhao; Renyu Ding; Yina Liu; Xiaohan Yin; Zhidan Zhang; Xiaochun Ma
Journal:  Exp Ther Med       Date:  2017-09-29       Impact factor: 2.447

6.  On the Process of Discovering Leads That Target the Heparin-Binding Site of Neutrophil Elastase in the Sputum of Cystic Fibrosis Patients.

Authors:  Shravan Morla; Nehru Viji Sankaranarayanan; Daniel K Afosah; Megh Kumar; Apparao B Kummarapurugu; Judith A Voynow; Umesh R Desai
Journal:  J Med Chem       Date:  2019-05-28       Impact factor: 7.446

7.  The effects of heparin on the adhesion of human peripheral blood mononuclear cells to human stimulated umbilical vein endothelial cells.

Authors:  A Smailbegovic; R Lever; C P Page
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Molecular principles for heparin oligosaccharide-based inhibition of neutrophil elastase in cystic fibrosis.

Authors:  Apparao B Kummarapurugu; Daniel K Afosah; Nehru Viji Sankaranarayanan; Rahaman Navaz Gangji; Shuo Zheng; Thomas Kennedy; Bruce K Rubin; Judith A Voynow; Umesh R Desai
Journal:  J Biol Chem       Date:  2018-06-14       Impact factor: 5.157

9.  Novel low molecular weight lignins as potential anti-emphysema agents: In vitro triple inhibitory activity against elastase, oxidation and inflammation.

Authors:  Bhawana Saluja; Jay N Thakkar; Hua Li; Umesh R Desai; Masahiro Sakagami
Journal:  Pulm Pharmacol Ther       Date:  2012-12-29       Impact factor: 3.410

10.  Binding to heparan sulfate or heparin enhances neutrophil responses to interleukin 8.

Authors:  L M Webb; M U Ehrengruber; I Clark-Lewis; M Baggiolini; A Rot
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.